Acadia Pharmaceuticals Inc.
$4.96B- Market cap
- $4.83B
- Debt
- +$306.51M
- Cash
- −$177.70M
Capital structure 94% equity / 6% debt · EV / Revenue 4.63x · EV / EBITDA 32.90x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ACAD · current priceP/S 4.51x
$28.02Latest market snapshot
Implied fair value · at KODK's multiple
$5.2981.1% below market
6.22 ACAD revenue / share×0.85x KODK P/S=$5.29
Market $28.02Implied $5.29
KODK · current priceP/S 0.85x
$9.29Latest market snapshot
Implied fair value · at ACAD's multiple
$49.20429.6% above market
10.92 KODK revenue / share×4.51x ACAD P/S=$49.20
Market $9.29Implied $49.20